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Ficolins are pathogen-recognition molecules in innate immune systems. The
crystal structure of the human M-ﬁcolin recognition domain (FD1) has been
determined at 1.9 A ˚ resolution, and compared with that of the human ﬁbrinogen
  fragment, tachylectin-5A, L-ﬁcolin and H-ﬁcolin. The overall structure of FD1
is similar to that of the other proteins, although the peptide bond between
Asp282 and Cys283, which is in a predicted ligand-binding site, is a normal trans
bond, unlike the cases of the other proteins. Analysis of the pH-dependent
ligand-binding activity of FD1 in solution suggested that a conformational
equilibrium between active and non-active forms in the ligand-binding region,
involving cis-trans isomerization of the Asp282—Cys283 peptide bond,
contributes to the discrimination between self and non-self, and that the pKa
values of His284 are 6.1 and 6.3 in the active and non-active forms, respectively.
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1. Introduction
Innate immune systems play a crucial role as the ﬁrst line of defense
against pathogens, and are present in all multicellular organisms,
including humans (Fujita et al., 2004). Ficolins, which are composed of
a collagen-like domain at the N-terminus and a ﬁbrinogen-like
domain (FBG) at the C-terminus, are one of the most important
groups of pattern-recognition molecules in innate immune systems.
Ficolins form trimer-based multimers that are mutually linked by
intermolecular disulﬁde bonds at the N-terminal domain (Ohashi &
Erickson, 2004). Three human ﬁcolins, M-ﬁcolin in cells and L-ﬁcolin
and H-ﬁcolin in serum, have been characterized. The amino acid
sequence homologies between M-ﬁcolin and L-ﬁcolin, and between
H-ﬁcolin and either L-ﬁcolin or M-ﬁcolin, are 80 and 48%, respec-
tively (Endo et al., 1996; Sugimoto et al., 1998). These ﬁcolins are
associated with the mannose binding lectin-associated serine
proteases, and the complexes activate the lectin-complement pathway
(Fujita et al., 2004; Liu et al., 2005; Frederiksen et al., 2005). The FBGs
of ﬁcolins bind to sugars, such as N-acetyl-d-glucosamine (GlcNAc)
onthe pathogen surface(Le etal., 1998; Teh etal., 2000). Interestingly,
although the sugars recognized by ﬁcolins also exist on the surface of
the host cell, the proteins can discriminate between the host cell (self)
and pathogens (non-self). To investigate the detailed mechanism of
discrimination between self and non-self by ﬁcolins, we have deter-
mined the crystal structure of the human M-ﬁcolin FBG domain
(FD1) at 1.9 A ˚ resolution, using synchrotron radiation at beamline
BL24XU at the SPring-8 facility in Japan (PDB code 2d39; Tanio et
al., 2006, 2007). The crystal structure of FD1, together with its pH-
dependent ligand binding activity, provides insight into the discri-
mination mechanism by ﬁcolins.
2. Trimeric structure of FD1
Diffraction-quality FD1 crystals were obtained at 293 K by mixing
0.5 ml protein solution (8 mg ml
 1 FD1, 8 mM Tris-HCl pH 8.0,
80 mM NaCl, 4 mM CaCl2 and 20 mM GlcNAc) and 0.5 ml reservoir
solution [100 mM MES pH 5.6, 320 mM Li2SO4 and 17%(w/v) PEG
4000] (Tanio et al., 2006). The crystal structure of FD1 was solved by
molecular replacement using the crystal structure of tachylectin-5A
(PDB code 1jc9; Kairies et al., 2001). The structure contains one
trimeric form of FD1 in the asymmetric unit (Tanio et al., 2007). The
overall structure of the FD1 monomer is similar to that of tachylectin-
5A (Kairies et al., 2001) and the human ﬁbrinogen   fragment (Pratt
et al., 1997; Yee et al., 1997), and consists of three domains (A, B and
P; Fig. 1), as in the other two proteins. The amino acid sequence of
FD1 is 49% and 45% identical to that of the FBG domain of
tachylectin-5A and the human ﬁbrinogen   fragment, respectively.
The crystal structure revealed that the hydrophobic side-chains of
Phe127 and Leu128 are important for trimer formation by FD1
(Tanio et al., 2007). Indeed, the replacement of Phe127 with Thr in
FD1 drastically decreased the monomer–monomer interaction in
solution, as judged by a dynamic light-scattering experiment (data not
shown). In spite of the addition of GlcNAc to the protein solution for
crystallization, no obvious electron density for the ligand was
observed, probably because FD1 at pH < 6 shows low GlcNAc-
binding activity (Fig. 2a). The ligand-binding study of FD1 in solution
revealed that the ligand-binding site is located near the Ca
2+ binding
site, the Cys270—Cys283 disulﬁde bond, and an unidentiﬁed group
with a pKa of 6.2 (Tanio et al., 2007). The group with a pKa of 6.2 was
tentatively assigned to His284. The predicted GlcNAc-binding sites
on the trimeric FD1 form the vertices of an equilateral triangle, witheach side approximately 50 A ˚ in length. Interestingly, the sugar-
binding sites of collectins also form the vertices of a similar-sized
triangle on each trimeric carbohydrate recognition domain, although
the FD1 and collectin structures are quite different. The common
spatial arrangement of the ligand-binding sites on each of the
proteins suggests that such an arrangement is universally required to
recognize pathogen-associated molecular patterns, and that a triangle
of this size is a basic trivalent recognition unit for general pathogens.
3. Conformational equilibrium of the ligand-binding site of
FD1
We previously developed a model describing the conformational
equilibrium at the P domain between the active (A) and non-active
(N) states at any pH, from an analysis of the pH-dependent GlcNAc-
binding activity of FD1 in solution (Tanio et al., 2007). In this model
the equilibrium depends on the state of a group with a pKa of 6.2,
which is probably the His284 side-chain. To obtain further informa-
tion about the group in terms of the pH dependency, we propose the
following model [Fig. 2(a), inset scheme], which is equivalent to our
previous model (Tanio et al., 2007), but distinguishes the pKa value of
the group between the active and non-active states. The relative
fraction of the active form of FD1 in this model is described by the
following equation,
factiveðpHÞ¼
1 þ 10nðpH pKAÞ
1 þ K2 þð 1 þ K1Þ10nðpH pKAÞ ; ð1Þ
¼ 1  
1 þ 10nðpH pKNÞ
1 þ K 1
2 þð 1 þ K 1
1 Þ10nðpH pKNÞ ; ð2Þ
where K1 = [N]/[A] and K2 = [NHn]/[AHn] are the equilibrium
constants between the active and non-active forms in the deproto-
nated and protonated states, respectively, and n is the number of
protons involved in the transition from the protonated (AHn and
NHn) to deprotonated (A and N) forms. pKA and pKN are the pKa of
the group related to the pH dependency in the active and non-active
states, respectively. The curve ﬁtting by equations (1) and (2)
revealed that K1, K2,p KA,p KN and n are 0.4, 1.9, 6.1, 6.3 and 2.8,
respectively [Fig. 2(a), solid line, coefﬁcient of determination r
2 =
0.99]. These values, except for pKA and pKN, are identical to those of
our previous model (Tanio et al., 2007). Although the pKAvalue (6.1)
is slightly lower than the pKN value (6.3), this difference is signiﬁcant.
The relationship between pKA and pKN is described by the following
equation,
K
n
N ¼
N ½  H ½ 
n
NHn
 ¼
K1 A ½  H ½ 
n
K2 AHn
 ¼
K1
K2
K
n
A
, pKA   pKN ¼
1
n
log
K1
K2
: ð3Þ
Therefore, if K1 < K2, then pKA <p KN in this model. Since the
increase in the GlcNAc-binding activity of FD1 associated with
increased pH results in K1 < K2 (Fig. 2a), the situation of pKA <p KN
is corollary. This means that the group related to the pH-dependent
diffraction structural biology
244 Michikazu Tanio et al.   M-ficolin fibrinogen-like domain J. Synchrotron Rad. (2008). 15, 243–245
Figure 2
(a) pH-dependent GlcNAc binding activity of FD1 at 277 K. The relative fractions, calculated as the eluted FD1 per total amount of protein applied to the GlcNAc column,
are plotted against the pH (Tanio et al., 2007). The solid line is the regression curve, as calculated from equations (1) or (2) (see text). The calculation revealed that K1, K2,
pKA,p KN and n are 0.41   0.03, 1.94   0.10, 6.06   0.04, 6.30   0.04 and 2.81   0.46, respectively. The inset is the scheme of the equilibrium model proposed here. (b)
Proposed conformational equilibrium between the active (slate) and non-active (magenta) forms of the P domain of FD1. In the active form the peptide bond between
Asp282 and Cys283 is in the cis conﬁguration. The putative model of the active conformation complexed with GlcNAc was built based on the crystal structure of tachylectin-
5A complexed with GlcNAc (Kairies et al., 2001).
Figure 1
Comparison of the main chain traces between FD1 (magenta) and the FBG domain
of L-ﬁcolin (Garlatti et al., 2007). Each Ca
2+ ion is shown as a sphere. S–S indicates
the conserved disulﬁde bonds in the two proteins. The conserved histidine residues
(H284 in FD1 and H246 in L-ﬁcolin) are shown as sticks. The root-mean-square
deviation between the two proteins is 0.73 A ˚ for 190 C  positions.activity of FD1 exists in different environments between the active
and non-active states; that is, the conformational difference exists in
the ligand-binding region between the two states. If the group is a
basic residue such as histidine, then its side-chain in the active state
should be located within a more hydrophobic environment than that
in the non-active state.
A comparison of the structure of FD1 with the ligand-binding
structures of tachylectin-5A (Kairies et al., 2001), the human ﬁbri-
nogen   fragment (Pratt et al., 1997) and two other ﬁcolins (L and H)
(Garlatti et al., 2007) shows that the predicted ligand-binding site of
FD1 is in good agreement with the ligand-binding sites of the other
four proteins. However, the conformation of the ligand-binding site
of FD1 is different from those of the other four proteins (Fig. 1, Tanio
et al., 2007). Interestingly, the side-chains of the conserved histidine
residues on the ligand-binding sites in tachylectin-5A (His220), the
human ﬁbrinogen   fragment (His340) and L-ﬁcolin (His246), which
correspond to His284 of FD1, are apparently buried in the surface of
each protein, while that of His284 of FD1 is exposed to the solvent
from the protein surface (Fig. 1). Such different environments around
the histidine residues would cause the different pKa values of the
residues between FD1 and the other three proteins, and therefore
His284 of FD1 is a strong candidate for the group with the pKA of 6.1
and the pKN of 6.3. In this connection, the peptide bond between
Asp282 and Cys283, neighboring His284, is a normal trans bond in
FD1, while the corresponding regions of the other four proteins are
an unusual cis peptide bond which is necessary for ligand binding
(Pratt et al., 1997; Kairies et al., 2001; Garlatti et al., 2007). From these
ﬁndings we propose a model of conformational equilibrium at the P
domain of FD1, involving cis-trans isomerization of the Asp282—
Cys283 peptide bond (Fig. 2b).
Although the conformational equilibrium of FD1 would cause
weak afﬁnity for the ligand, it is crucial to prevent self-recognition.
The low ligand density on the surfaces of self-cells also contributes to
the prevention of self-recognition. On the other hand, the M-ﬁcolin
multimer, which is an assemblage of the trivalent recognition unit
(Tanio et al., 2007), has an advantage in recognizing surfaces with high
ligand density composed of pathogen-associated molecular patterns.
Therefore, the multimerization based on the trivalent recognition
unit is an important property for recognizing non-self, whereas the
weak afﬁnity of each molecule is an essential feature for preventing
self-recognition. This strategy of the innate immunity systems
provides a structural basis for understanding the mechanism of
discrimination between self and non-self, and for designing selective
drugs for targets, such as general pathogens and aberrantly glycosy-
lated cancer cells.
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